Sinuforte lyophilized powder for intranasal administration 50mg 1 pc + solvent / doser-dispenser

$48.50

Sinuforte lyophilized powder for intranasal administration 50mg 1 pc + solvent / doser-dispenser

Quantity:

Description

Composition
Active substance:
a) a bottle with the active component comprises a lyophilisate cyclamen tuber juice and extract fresh European (hemolytic index 1: 6000 -1: 12000) – 50 mg b) with the solvent vial contains: Water for injection – 5 ml
Description:
The lyophilizate from white to light brown, hygroscopic.
The solvent was “water for injection” – a transparent colorless liquid.
The solution obtained after dissolving 0.05 g in 5 ml of water, must be color from colorless to pale yellow.
Product form:
Lyophilizate for preparation of solution for intranasal administration. 50 mg product (a haemolytic index of 1: 6000-1: 12000) in a bottle made of colorless glass (hydrolytic class 1 EF), a sealed rubber stopper of type 1 (EF) and screwed plastic cap.
Each vial with the solvent vial (5 ml of water for injections in a plastic vial, sealed with rubber) and spray nozzle was placed in a plastic tray. The pallet together with instructions for use placed in a cardboard box.
Contraindications
-Increasing sensitivity to the drug; -Polipoznye rhinosinusitis; -Kisty paranasal sinuses;
-Allergicheskie rhinosinusopathy;
-Allergicheskie reaction (immediate and delayed type);
-Arterialnaya hypertension P-W st .;
-Pregnancy and lactation (use safety during these periods has not been studied); -Children under the age of 5 years (the use in children younger than 5 years has not been studied).
Dosage
50 mg
Indications
Is the complex therapy of acute and chronic sinusitis: sinusitis, frontal sinusitis, and etmoidita sfenoidity (in the case of purulent sinusitis, occurring with symptoms *
generalization of infection, and / or the orbital complications Sinuforte® should only be used in combination with antibiotics). In uncomplicated disease course possible to use the drug as monotherapy under medical supervision;
Is the complex therapy of rhinosinusitis, accompanied by otitis media with effusion;
Is the period of early postoperative rehabilitation after endoscopic surgery of the paranasal sinuses.
Interaction with other drugs
It is necessary to refrain from the prior administration, and the simultaneous application of local anesthetics and / or local decongestants for a possible violation of the mechanism of action Sinuforte® preparation.
If necessary, possible and permissible Sinuforte® combination preparation with antibacterial drugs.
Interaction with other drugs has not yet been studied.
Overdose
Currently, the cases of drug overdose Sinuforte® were reported. Exceeding single dose does not lead to an increase in the therapeutic effect, and can cause severe burning sensation and pain in the nose and throat.
When the overdose symptoms should spend symptomatic therapy: rinse the nasal cavity, throat, rinse with warm water and apply an antihistamine.
pharmachologic effect
Pharmacological group:
wasp disease treatment agent.
CODE ATX: R01AX
Pharmacodynamics:
The preparation of vegetable origin for the treatment of inflammatory diseases of the paranasal sinuses (ONP) and nasal cavity. The drug acts on the sensory receptors of the trigeminal nerve in the middle meatus and causes reflex secretion in the mucosa of the nasal cavity and SNPs. Stimulated hypersecretion accompanied by changes in the rheological properties of secretion and normalizing its viscosity. Reflector hypersecretion in combination with anti-edematous action of the drug leads to evacuation of secretions in the sinuses and nasopharynx provides physiological drainage of the sinuses simultaneously. The drug helps to restore the mucociliary transport in nasal cavity and SNPs by increasing the presence in the surface layer portion of the liquid mucus secretion. Sinuforte® enhances blood microcirculation in the mucosa of the nose and the UNP. This is due to the fact that parasympathetic stimulation that activates secretion, also causes vasodilation of vessels that supply cancer.
Strong reflex secretion as sero-mucosal secretions is detected after a few minutes and may last from 30 to 120 minutes depending on the individual.
Pharmacokinetics:
Sinuforte® effect of the drug due to the cumulative effect of the components of cyclamen, the most studied of which are triterpene saponins. A kinetic studies is not possible, since all the components together, might not be. traced using markers or research. For the same reason it is impossible to detect and drug metabolites.
Conditions of supply of pharmacies
Without recipe
side effects
Perhaps the emergence of a sense of light or moderate burning sensation in the nasal cavity, salivation and / or tearing in response to stimulation of the sensory receptors of the trigeminal nerve.
In some cases it may be redness of the face, a brief headache in the frontal region or appear painted in a pale pink color discharge from the nose as a result of capillary diapedesis. The above short-term physiological responses confirm the reflex mechanism of action of the drug and do not require discontinuation of treatment.
Allergic reactions (including skin rash, shortness of breath, etc.). In these cases it is recommended to stop taking the drug and consult a specialist.
special instructions
During the postoperative rehabilitation after endoscopic interferences Sinuforte® applied on the second day for purification (sanitation), the paranasal sinuses and nasal mucosa and reduce edema.
When using Sinuforte® avoid contact with the eyes due to the presence of irritating effect of the preparation on the mucous membrane of the eye and possible development of an acute conjunctivitis phenomena.
During injection it is recommended to hold your breath.
Direct spraying of the preparation should be carried out at one-touch upright head.
Prior to use, we recommend consulting a doctor, otolaryngologist.
Storage conditions
At temperatures above 25 ° C, protected from light.
After dilution of drug is stored at 2 to 8 ° C for 15 days in a dark place.
Keep out of the reach of children!
Dosing and Administration
Intranasally.
Adults and children over 5 years:
1. Unscrew the cap from the vial and remove the cap.
2. Open the vial solvent broke off the top.
3. Fully pour the contents into the solvent vial.
4. Screw spray dispenser bottle in and shake to complete dissolution of the drug.
5. Remove the protective cap with a metering sprayer.
6. Make 2-3 test spraying in the air.
7. When the vertical position of the head to enter the spray dispenser in each nostril, hold their breath and make sputtering one click
Each time the dispenser sprays 0.13 ml (2-3 drops) of the drug, which is about 1.3 mg dose (single dose) .- preparation prepared by the above method is administered once a day by a single spray into each nostril. 2-3 previously recommended to test spray into the air.
The drug is recommended to be used daily, if necessary, also allowed its use in a day.
The duration of one treatment course is 12-16 days upon administration of the drug through the day, or for 6-8 days with daily application.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

EGIS

There are no reviews yet.

Add your review